[1]
2026. Correlation between Diabetic Control and Visual Outcomes of Aflibercept versus Bevacizumab Therapy in Iraqi Patients with Diabetic Macular Edema. Al Mustansiriyah Journal of Pharmaceutical Sciences. 26, 1 (Mar. 2026), 147–161. DOI:https://doi.org/10.32947/ajps.v26i1.1385.